GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Advanced Proteome Therapeutics Corp (OTCPK:APTCF) » Definitions » FCF Yield %

Advanced Proteome Therapeutics (Advanced Proteome Therapeutics) FCF Yield % : 0.00 (As of May. 24, 2024)


View and export this data going back to 2006. Start your Free Trial

What is Advanced Proteome Therapeutics FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, Advanced Proteome Therapeutics's Trailing 12-Month Free Cash Flow is $-1.31 Mil, and Market Cap is $0.15 Mil. Therefore, Advanced Proteome Therapeutics's FCF Yield % for today is 0.00%.

The historical rank and industry rank for Advanced Proteome Therapeutics's FCF Yield % or its related term are showing as below:


APTCF's FCF Yield % is not ranked *
in the Biotechnology industry.
Industry Median: -14.35
* Ranked among companies with meaningful FCF Yield % only.

Advanced Proteome Therapeutics's FCF Margin % for the quarter that ended in Apr. 2023 was 0.00%.


Advanced Proteome Therapeutics FCF Yield % Historical Data

The historical data trend for Advanced Proteome Therapeutics's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Advanced Proteome Therapeutics FCF Yield % Chart

Advanced Proteome Therapeutics Annual Data
Trend Jul13 Jul14 Jul15 Jul16 Jul17 Jul18 Jul19 Jul20 Jul21 Jul22
FCF Yield %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -16.78 -29.74 -17.24 -5.19 -19.99

Advanced Proteome Therapeutics Quarterly Data
Jul18 Oct18 Jan19 Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23
FCF Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -443.58 -25.18 -28.46 -13.18 -188.69

Competitive Comparison of Advanced Proteome Therapeutics's FCF Yield %

For the Biotechnology subindustry, Advanced Proteome Therapeutics's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Advanced Proteome Therapeutics's FCF Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Advanced Proteome Therapeutics's FCF Yield % distribution charts can be found below:

* The bar in red indicates where Advanced Proteome Therapeutics's FCF Yield % falls into.



Advanced Proteome Therapeutics FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

Advanced Proteome Therapeutics's FCF Yield % for the fiscal year that ended in Jul. 2022 is calculated as

FCF Yield %=Free Cash Flow / Market Cap
=-0.708 / 3.542371488
=-19.99%

Advanced Proteome Therapeutics's annualized FCF Yield % for the quarter that ended in Apr. 2023 is calculated as

FCF Yield %=Free Cash Flow * Annualized Factor / Market Cap
=-0.712 * 4 / 1.50936457
=-188.69%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Advanced Proteome Therapeutics FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.


Advanced Proteome Therapeutics FCF Yield % Related Terms

Thank you for viewing the detailed overview of Advanced Proteome Therapeutics's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.


Advanced Proteome Therapeutics (Advanced Proteome Therapeutics) Business Description

Traded in Other Exchanges
Address
8337 Eastlake Drive, Suite 104, Burnaby, BC, CAN, V5A 4W2
Advanced Proteome Therapeutics Corp is a biotechnology company. It develops and commercializes a platform to use protein modification technologies to create proprietary human protein pharmaceuticals with therapeutic properties. The company develops anti-cancer drugs for cancerous tumors that will destroy a cancer patient's tumor cells selectively, sparing healthy cells. All the operations of the organization are principally carried out in the United States.

Advanced Proteome Therapeutics (Advanced Proteome Therapeutics) Headlines